Potential Drugs for Huntington's Disease Found in Worms
Author Information
Author(s): Cindy Voisine, Hemant Varma, Nicola Walker, Emily A. Bates, Brent R. Stockwell, Anne C. Hart
Primary Institution: Massachusetts General Hospital Cancer Center
Hypothesis
Can FDA approved drugs effectively suppress neurotoxicity in a C. elegans model of Huntington's disease?
Conclusion
Lithium chloride and mithramycin can protect against neurotoxicity in Huntington's disease models, suggesting they may be useful for therapy.
Supporting Evidence
- Lithium chloride and mithramycin were found to independently suppress neurotoxicity.
- The drugs were effective in a C. elegans model, which is a simpler organism.
- The study suggests that the mechanisms of neuroprotection are distinct from aging pathways.
Takeaway
Researchers tested two existing drugs on tiny worms to see if they could help with a brain disease called Huntington's. They found that these drugs worked well to protect the worms' brain cells.
Methodology
The study screened FDA approved drugs in a C. elegans model of Huntington's disease to assess their neuroprotective effects.
Limitations
The study primarily used a model organism, which may not fully replicate human disease conditions.
Statistical Information
P-Value
p<0.0001 for 25 mM LiCl; p=0.037 for 0.5 mM MTR; p<0.0001 for 1 mM MTR
Statistical Significance
p<0.0001
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website